高海拔地区H型高血压患者血管内皮功能与氧化应激的研究进展

doi:10.12114/j.issn.1007-9572.2024.0040

摘要/Abstract

摘要： 高海拔地区低压、低氧环境致人体内代谢水平发生一系列变化，其特殊环境使体内氧化应激水平、同型半胱氨酸水平升高，从而损伤血管内皮细胞，高同型半胱氨酸血症会加剧氧化应激，进一步加重对血管内皮的损伤，加速高血压的发生、发展。在传统降压药治疗的基础上联合使用抗氧化药物可为高海拔地区H型高血压的治疗提供新方向。本文主要就高海拔地区H型高血压患者血管内皮功能与氧化应激的关系进行综述，探索其发病机制及可能的治疗方法。

关键词: 高血压, H型高血压, 高同型半胱氨酸血症, 血管内皮细胞

Abstract:

The low-pressure and low-oxygen environment at high altitude causes a series of changes in the metabolic level in the human body. The high altitude environment increases the level of oxidative stress and homocysteine in the body, which damages vascular endothelial cells. Hyperhomocysteinemia exacerbates oxidative stress, further aggravates the damage to the vascular endothelium, and accelerates the occurrence and development of hypertension. The combination of antioxidant drugs on the basis of traditional antihypertensive drug treatment provides a new direction for the treatment of H-type hypertension in high-altitude areas. This article reviews the relationship between vascular endothelial function and oxidative stress in patients with H-type hypertension in high-altitude areas, and explores its pathogenesis and possible treatments.

Key words: Hypertension, H-type hypertension, Hyperhomocysteinemia, Vascular endothelial cells

张柠,樊世明. 高海拔地区H型高血压患者血管内皮功能与氧化应激的研究进展[J]. 中国全科医学, 2024, 27(27): 3435-3439. DOI: 10.12114/j.issn.1007-9572.2024.0040.
ZHANG Ning,FAN Shiming. Research Progress on Vascular Endothelial Function and Oxidative Stress in Patients with H-type Hypertension at High Altitudes[J]. Chinese General Practice, 2024, 27(27): 3435-3439. DOI: 10.12114/j.issn.1007-9572.2024.0040.

参考文献 52

[1]	VAN OORT S，BEULENS J W J，VAN BALLEGOOIJEN A J，et al. Association of cardiovascular risk factors and lifestyle behaviors with hypertension：a Mendelian randomization study[J]. Hypertension，2020，76（6）：1971-1979. DOI：10.1161/HYPERTENSIONAHA.120.15761.
[2]	RENGARAJAN A，GOLDBLATT H E，BEEBE D J，et al. Immune cells and inflammatory mediators cause endothelial dysfunction in a vascular microphysiological system[J]. Lab Chip，2024，24（6）：1808-1820. DOI：10.1039/d3lc00824j.
[3]	周振，汤锋，格日力. 高原低氧环境下影响肺动脉压力的相关因素分析[J]. 生理学报，2023，75（1）：130-136. DOI：10.13294/j.aps.2023.0003.
[4]	KOTLYAROV S. Immune function of endothelial cells：evolutionary aspects，molecular biology and role in atherogenesis[J]. Int J Mol Sci，2022，23（17）：9770. DOI：10.3390/ijms23179770.
[5]	LI M，WU Y Q，YE L. The role of amino acids in endothelial biology and function[J]. Cells，2022，11（8）：1372. DOI：10.3390/cells11081372.
[6]	HOU J，YUAN Y，CHEN P，et al. Pathological roles of oxidative stress in cardiac microvascular injury[J]. Curr Probl Cardiol，2023，48（1）：101399. DOI：10.1016/j.cpcardiol.2022.101399.
[7]	DRI E，LAMPAS E，LAZAROS G，et al. Inflammatory mediators of endothelial dysfunction[J]. Life，2023，13（6）：1420. DOI：10.3390/life13061420.
[8]	KULOVIC-SISSAWO A，TOCANTINS C，DINIZ M S，et al. Mitochondrial dysfunction in endothelial progenitor cells：unraveling insights from vascular endothelial cells[J]. Biology，2024，13（2）：70. DOI：10.3390/biology13020070.
[9]	中国营养学会骨健康与营养专业委员会，中华医学会肠外肠内营养学分会，中国老年医学学会北方慢性病防治分会. 高同型半胱氨酸血症诊疗专家共识[J]. 肿瘤代谢与营养电子杂志，2020，7（3）：283-288. DOI：10.16689/j.cnki.cn11-9349/r.2020.03.007.
[10]	YUAN D，CHU J，LIN H，et al. Mechanism of homocysteine-mediated endothelial injury and its consequences for atherosclerosis[J]. Front Cardiovasc Med，2023，9：1109445. DOI：10.3389/fcvm.2022.1109445.
[11]	ESSE R，BARROSO M，DE ALMEIDA I T，et al. The contribution of homocysteine metabolism disruption to endothelial dysfunction：state-of-the-art[J]. Int J Mol Sci，2019，20（4）：867. DOI：10.3390/ijms20040867.
[12]	DU PLESSIS J P，LAMMERTYN L，SCHUTTE A E，et al. H-type hypertension among blackSouth Africa ns and the relationship between homocysteine，its genetic determinants and estimates of vascular function[J]. J Cardiovasc Dev Dis，2022，9（12）：447. DOI：10.3390/jcdd9120447.
[13]	OPARIL S，ACELAJADO M C，BAKRIS G L，et al. Hypertension[J]. Nat Rev Dis Primers，2018，4：18014. DOI：10.1038/nrdp.2018.14.
[14]	李建平，卢新政，霍勇，等. H型高血压诊断与治疗专家共识[J]. 中国实用内科杂志，2016，36（4）：295-299. DOI：10.3969/j.issn.1674-7372.2016.05.006.
[15]	KRZEMIŃSKA J，WRONKA M，MŁYNARSKA E，et al. Arterial hypertension-oxidative stress and inflammation[J]. Antioxidants，2022，11（1）：172. DOI：10.3390/antiox11010172.
[16]	PENA E，BRITO J，EL ALAM S，et al. Oxidative stress，kinase activity and inflammatory implications in right ventricular hypertrophy and heart failure under hypobaric hypoxia[J]. Int J Mol Sci，2020，21（17）：6421. DOI：10.3390/ijms21176421.
[17]	孙东倩，王泽昊，刘可欣，等. 老年H型高血压患者血清粘附因子及氧化应激指标与颈动脉粥样硬化的相关性研究[J]. 老年医学与保健，2022，28（3）：694-695，698. DOI：10.3969/j.issn.1008-8296.2022.03.051.
[18]	HERRMANN W，HERRMANN M. The controversial role of HCY and vitamin B deficiency in cardiovascular diseases[J]. Nutrients，2022，14（7）：1412. DOI：10.3390/nu14071412.
[19]	BURTSCHER M，HEFTI U，HEFTI J P. High-altitude illnesses：old stories and new insights into the pathophysiology，treatment and prevention[J]. Phys Med Health Sci，2021，3（2）：59-69. DOI：10.1016/j.smhs.2021.04.001.
[20]	FAN N，LIU C，REN M. Effect of different high altitudes on vascular endothelial function in healthy people[J]. Medicine，2020，99（11）：e19292. DOI：10.1097/MD.0000000000019292.
[21]	FAYAZI B，TADIBI V，RANJBAR K. The role of hypoxia related hormones responses in acute mountain sickness susceptibility individuals unaccustomed to high altitude[J]. PLoS One，2023，18（10）：e0292173. DOI：10.1371/journal.pone.0292173.
[22]	LI X，ZHANG J，LIU G，et al. High altitude hypoxia and oxidative stress：the new hope brought by free radical scavengers[J]. Life Sci，2024，336：122319. DOI：10.1016/j.lfs.2023.122319.
[23]	樊世明，任明，沈国满，等. 不同海拔地区高血压患者血管内皮舒张功能及其与氧化应激水平的相关性[J]. 中国高原医学与生物学杂志，2019，40（2）：99-104. DOI：10.13452/j.cnki.jqmc.2019.02.004.
[24]	PHAM K，PARIKH K，HEINRICH E C. Hypoxia and inflammation：insights from high-altitude physiology[J]. Front Physiol，2021，12：676782. DOI：10.3389/fphys.2021.676782.
[25]	CORTESE-ORTESE-KROTT M M. The reactive species interactome in red blood cells：oxidants，antioxidants，and molecular targets[J]. Antioxidants （Basel），2023，12（9）：1736. DOI：10.3390/antiox12091736.
[26]	SOLIMAN M M，ALDHAHRANI A，ALTHOBAITI F，et al. Characterization of the impacts of living at high altitude in taif：oxidative stress biomarker alterations and immunohistochemical changes[J]. Curr Issues Mol Biol，2022，44（4）：1610-1625. DOI：10.3390/cimb44040110.
[27]	JOCHMANS-LEMOINE A，REVOLLO S，VILLALPANDO G，et al. Divergent mitochondrial antioxidant activities and lung alveolar architecture in the lungs of rats and mice at high altitude[J]. Front Physiol，2018，9：311. DOI：10.3389/fphys.2018.00311.
[28]	包国平，马莲程，熊继珍，等. 高原地区H型高血压的相关危险因素和靶器官损害研究[J]. 中国医学工程，2021，29（5）：40-44. DOI：10.19338/j.issn.1672-2019.2021.05.010.
[29]	ZHANG Y W，YANG Y N，WU X M，et al. The association between altitude and the prevalence of hypertension among permanent highlanders[J]. Hypertens Res，2022，45（11）：1754-1762. DOI：10.1038/s41440-022-00985-2.
[30]	YANG J，JIN Z B，CHEN J，et al. Genetic signatures of high-altitude adaptation in Tibetans[J]. Proc Natl Acad Sci U S A，2017，114（16）：4189-4194. DOI：10.1073/pnas.1617042114.
[31]	格桑平措，熊海，万洋，等. 西藏极高海拔地区藏族血浆同型半胱氨酸水平与MTHFR和MTRR基因多态性的相关性分析[J]. 高原科学研究，2022，6（3）：84-91，110. DOI：10.16249/j.cnki.2096-4617.2022.03.011.
[32]	LIAO S，GUO S，MA R，et al. Association between methylenetetrahydrofolate reductase（MTHFR） C677T polymorphism and H-type hypertension：a systematic review and meta-analysis[J]. Ann Hum Genet. 2022，86（5）：278-289. DOI：10.1111/ahg.12468.
[33]	HA X Q，LI J，MAI C P，et al. The decrease of endothelial progenitor cells caused by high altitude may lead to coronary heart disease[J]. Eur Rev Med Pharmacol Sci，2021，25（19）：6101-6108. DOI：10.26355/eurrev_202110_26888.
[34]	NARVAEZ-GUERRA O，HERRERA-ENRIQUEZ K，MEDINA-LEZAMA J，et al. Systemic hypertension at high altitude[J]. Hypertension，2018，72（3）：567-578. DOI：10.1161/HYPERTENSIONAHA.118.11140.
[35]	LÓPEZ V，URIBE E，MORAGA F A. Activation of arginase Ⅱ by asymmetric dimethylarginine and homocysteine in hypertensive rats induced by hypoxia：a new model of nitric oxide synthesis regulation in hypertensive processes?[J]. Hypertens Res，2021，44（3）：263-275. DOI：10.1038/s41440-020-00574-1.
[36]	SUN P，WANG Q，ZHANG Y，et al. Association between homocysteine level and blood pressure traits among Tibetans：A cross-sectional study in China[J]. Medicine （Baltimore），2019，98（27）：e16085. DOI：10.1097/MD.0000000000016085.
[37]	MINGJI C，ONAKPOYA IJ，PERERA R，et al. Relationship between altitude and the prevalence of hypertension in Tibet：a systematic review[J]. Heart. 2015，101（13）：1054-1060. DOI：10.1136/heartjnl-2014-307158.
[38]	索朗德吉，次仁仲嘎. 西藏地区不同人群H型高血压患病率及影响因素分析[J]. 西藏科技，2023（3）：71-75.
[39]	AN X，DU X，YANG B，et al. Prognostic impact of serum homocysteine-lowering therapy on patients with hemorrhagic stroke and its influence on national institutes of health stroke scale and China stroke scale scores[J]. Altern Ther Health Med，2024，30（1）：381-385.
[40]	CHEN P，TANG L，SONG Y，et al. Association of folic acid dosage with circulating unmetabolized folic acid in Chinese adults with H-type hypertension：a multicenter，double-blind，randomized controlled trial[J]. Front Nutr，2023，14（10）：1191610. DOI：10.3389/fnut.2023.1191610.
[41]	JI D，LUO C，LIU J，et al. Insufficient S-sulfhydration of methylenetetrahydrofolate reductase contributes to the progress of hyperhomocysteinemia[J]. Antioxid Redox Signal，2022，36（1-3）：1-14. DOI：10.1089/ars.2021.0029.
[42]	GONZÁLEZ-LAMUÑO D，ARRIETA-BLANCO F J，FUENTES E D，et al. Hyperhomocysteinemia in adult patients：a treatable metabolic condition[J]. Nutrients，2023，16（1）：135. DOI：10.3390/nu16010135.
[43]	MOLL S，VARGA E A. Homocysteine and MTHFR mutations[J]. Circulation，2015，132（1）：e6-9. DOI：10.1161/CIRCULATIONAHA.114.013311.
[44]	GADANEC L K，ANDERSSON U，APOSTOLOPOULOS V，et al. Glycyrrhizic acid inhibits high-mobility group box-1 and homocysteine-induced vascular dysfunction[J]. Nutrients，2023，15（14）：3186. DOI：10.3390/nu15143186.
[45]	KONG J Y，DENG Y. Pirfenidone alleviates vascular intima injury caused by hyperhomocysteinemia[J]. Rev Port Cardiol，2022，41（10）：813-819. DOI：10.1016/j.repc.2021.12.011.
[46]	DE LUCA M，VALVANO A，STRIANO P，et al. Effects of three-months folate supplementation on early vascular abnormalities in hyperhomocysteinemic patients with epilepsy[J]. Seizure，2022，103：120-125. DOI：10.1016/j.seizure.2022.11.009.
[47]	PENA E，EL ALAM S，SIQUES P，et al. Oxidative stress and diseases associated with high-altitude exposure[J]. Antioxidants，2022，11（2）：267. DOI：10.3390/antiox11020267.
[48]	YOUN JY，ZHANG J，ZHANG Y，et al. Oxidative stress in atrial fibrillation：an emerging role of NADPH oxidase[J]. J Mol Cell Cardiol，2013，62：72-79. DOI：10.1016/j.yjmcc.2013.04.019.
[49]	CHEN D，ZANG Y H，QIU Y，et al. BCL6 attenuates proliferation and oxidative stress of vascular smooth muscle cells in hypertension[J]. Oxid Med Cell Longev，2019：5018410. DOI：10.1155/2019/5018410.
[50]	BASU U，CASE AJ，LIU J，et al. Redox-sensitive calcium/calmodulin-dependent protein kinase Ⅱα in angiotensin Ⅱ intra-neuronal signaling and hypertension[J]. Redox Biol，2019，27：101230. DOI：10.1016/j.redox.2019.101230.
[51]	STONE R M，AINSLIE P N，TREMBLAY J C，et al. GLOBAL REACH 2018：intra-arterial vitamin C improves endothelial-dependent vasodilatory function in humans at high altitude[J]. J Physiol，2022，600（6）：1373-1383. DOI：10.1113/JP282281.
[52]	AMPONSAH-OFFEH M，DIABA-NUHOHO P，SPEIER S，et al. Oxidative stress，antioxidants and hypertension[J]. Antioxidants，2023，12（2）：281. DOI：10.3390/antiox12020281.